Monday, 2 January 2017

Dental Instruments and Appliances Market driven by increasing awareness about dental care

Dental instruments and appliances are the tools that are used by the dental professionals to examine, restore, manipulate tissues or extract teeth. Moreover, these are also used to treat all kinds of dental disorders or deformities. Some of the common dental tools and appliances include dental mirrors, dental probes and retractors, dental hand pieces or dental drills and dental burs. Dental drills are the most used instruments in dental treatment. Dental drill is a high-speed drill used for decay removal and shaping the tooth structure before inserting a filling or a dental crown or even to remove old and temporary fillings before the insertion of new or permanent crown or filling. As per current global demand, dental drill engines occupy around 9% of the global market leaving the rest of the market share for the other dental instruments and appliances. Dental hand pieces/engines are available in various types depending on the speed (also known as an airotor), friction grip etc.
According to a global study published by the World Health Organization (WHO) in 2012, dental caries are one of the major oral health problems in most countries. About 60% to 90% of school children and nearly 100% of adults have cavities. As a counter measure, the World Health Organization (WHO) has taken initiatives to promote the prevention of oral diseases across the globe which in turn might result in a rise in the number of dental diagnostic instruments and appliances. The study says the oral diseases are more observed in low- and middle-income countries and the prevalence rate of oral diseases is varied depending on the geographical region, availability and accessibility to the oral health services. In many developing countries, access to oral health services is limited and oral care is often neglected. On the other hand, a study by the Centres for Disease Control and Prevention revealed that about 30% of people aged 65–74 have no natural teeth which can be partly attributed to neglected oral care.
The demand for cosmetic dentistry and the increasing dental tourism has led to an increase in sophisticated and advanced dental appliances. Other factors supporting the industry growth are the rising geriatric population, and increasing awareness about dental care. Tough the heavy taxation on dental devices and high cost, advanced dental equipment can hamper the growth of the market.
North America dominates the dental instruments and appliances market owing to the high demand for dental procedures and growing incidences of oral health problems. Europe dental instruments and appliances market is on par with North America market banking on the demand for the products related to oral health and increased patient awareness. Asia Pacific is expected to register significant growth in the coming years owing to increased demand for dental care and high unmet demand of large patient pool. Other reasons for the market growth in this region is the introduction of innovative instruments and techniques. Furthermore, improving healthcare infrastructure due to the government initiatives is likely to boost the business environment in the region.
Key players in the global dental instruments and appliances market include Danaher Corporation, Planmeca OY, Dentsply Sirona, Carestream Health, Inc., A-dec Inc., AMD LASERS, Biolase, Inc., Midmark Corporation, and 3M Corporation.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
Posted by at No comments:
Labels: , , , ,

Demineralized Allografts Market grows with joint reconstruction because of rising number of pandemics

Bone grafts are generally utilized for bone regeneration, pain relief and structure restoration for decades all over the world. Conservatively, autografts were used for bone grafting, in which patient’s own bone was used as a graft. Autologous bone grafts have proven very useful and is recognized as a gold standard for bone transplant. On the contrary, use of autologous bone grafts embraces the risk of infection transfer. This infection transfer during surgical procedures at both tissue harvesting and transplant sites results in late wound healing and prolonged hospital stay. Therefore, allografts were introduced in the market for overcoming the disadvantages associated with autologous grafts. Allografts possess both osteoinductive and osteoconductive properties, and hence serve as a worthy substitute for autografts.
Demineralized allografts are also referred as DBMs. Two methods introduced for processing of donor tissue to obtain Demineralized Bone Matrix (DBM) include:
  • Grinding the bones into particulate powder
  • Milling the bones into fibers
DBMs that employ fibers exhibit better osteoconductive scaffold because of their interwoven structure. This interwoven structure gives bone forming cells an opportunity to migrate within the matrix instead of trying to “jump” the gaps between the particles. Demineralized Bone Matrix which uses the fiber technology are engineered in such a way that enhances their properties like osteoconduction. This property is very essential for the quicker healing of the orthopedic tissues after surgery.
Allografts comprise the tissues, cells and/or proteins that are utilized for implantation, infusion or transplant from donor to the recipient with different genetic makeup of the same species. DBM is the human bone processed with hydrochloric acid that removes the mineral content of the bone. After processing collagen, bone proteins and bone morphogenetic proteins are left. These demineralized allografts exhibit high osteoinductive properties alongside some osteoconductive properties with structural support. Demineralized allografts are readily available world over and are very popular substitutes of the bone autografts. These demineralized bone matrix is often combined with cortical and cancellous bone chips to improve osteoconductive properties. These can be utilized as autologous bone grafts extender in spinal and trauma surgeries. DBM is generally regulated by FDA’ 510K marketing clearing processes. Demineralized allografts if not combined with other materials then only it can be utilized for transplantation. Growth in demineralized allograft market is greater due to anticipated surge in soft-tissue allografts. Increasing demand for repair procedures related to growth in more active lifestyles among affluent younger people. The demineralized allograft market is expected to grow at huge CAGR because of new technological innovations in grafting, and increase in cosmetic surgery, etc. Zimmer has introduced Puros, a demineralized bone matrix which contains ground cortical cancellous chips from the donors.
The demineralized allografts market can be segmented based on product type, end-users and geography. Based on key product types, the market can be segmented into DBM with cortical bone chip, DBM with cancellous bone chip, DBM with adult mesenchymal stem cells, DBM with calcium sulfate, and DBM with calcium phosphate. Segmentation of this market on the basis of end user can be done as tertiary care hospitals, orthopedics hospitals, orthopedics OPD, and corporate hospitals. The segmentation of the global demineralized allografts market based on geography include regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Growth drivers of demineralized allografts market in the near future include increase in the volume of procedures like spinal fusion, and joint reconstruction because of rising number of pandemics, rapidly aging population and increasing obesity rates. In addition, continuous efforts in product innovations, and line extension of available products to create comprehensive orthobiologics platform from different manufacturers are also driving the global market. Orthopedic community’s continuous research on materials providing better osteoconductivity, osteoinductivity and osteogenesis, and improved accessibility to the latest generation allografts in emerging economics would further contribute toward this market growth in the near future.
Key players operating in the demineralized allografts market are Medtronic, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Bacterin International, Inc., Alphatec Spine, Inc., AlloSource, Zimmer Biomet Holdings, Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, NuVasive, Inc., Olympus Corporation, Orthofix Holdings, Inc., and RTI Surgical among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
Posted by at No comments:
Labels: , , , ,

Cardiac Output Monitoring Devices Market: North America have the major share due to high healthcare awareness, prevalence of cardiovascular diseases

Cardiac output is known as the volume of blood is pumped by from the right or left ventricle of heart per minute and which is dependent on heart rate, and stroke volume. The cardiac output increases during acute exercise and mental stress, while decreased cardiac output might include physical exercise of a intensity that the patient is not able to bear because of decrease in oxygen supply, obesity, ingestion of large meals that place an added workload on the heart, retention of fluid, emotional stress, hypervolemia, and smoking. It is essential to assess the state of patient’s blood circulation. Low cardiac output usually leads to a common problem of low blood pressure which might surface occur during surgery, or during postoperative care in the intensive care units.
In high-risk surgical patients and critically ill patients the arterial blood pressure and cardiac output usually are monitored more comprehensively. Cardiac output monitoring devices are used to know the cardiac output of heart and arterial oxygen content which enable the circulation of continuous systemic oxygen supply to the body. Doubling the cardiac output leads to double amount of the oxygen supply to the tissues, while the low cardiac output leads to inadequate supply of oxygen to organs like brain and the low amount of cellular oxygenation can cause tissue and organ failure. The major observed causative factors for the decrease cardiac output are congenital heart defects, pathologic changes in the heart's muscle, blood dyscrasias, chronic pulmonary disease and electrolyte imbalances (as of potassium or calcium). According to North American Nursing Diagnosis Association, decreased cardiac output is defined as a state in which inadequate blood is pumped by the heart to meet the metabolic demands of the body. Cardiac output monitoring devices market is classified on the basis of product type, methods, end-user and geography.
On the basis of product type the market is broadly classified into invasive, minimally-invasive and non-invasive cardiac output monitoring devices. The invasive cardiac output monitoring has been traditionally accomplished using the pulmonary artery catheter (PAC), but complications associated with PAC has markedly decreased the widespread use of the PAC. The market demand for the non- invasive devices is high followed by minimally invasive devices as compare to invasive devices, due to factors such as ease, accessibility and cost- effectiveness and fast response time. By methods the market is segmented as thermodilution method, pulse pressure analysis, Doppler method, bioimpedance and applied Fick principle. Each methods has its own merits and demerits. On the basis of end-user the market is segmented as hospitals, ambulatory care and critical care centers. By end-user hospitals covers the major market for cardiac output monitoring devices, because of reliability and conjunction of other therapeutic treatments. The factors such as raising incidences of cardiovascular diseases, increase in the number of people suffering from obesity, growing ageing population, and raising healthcare infrastructure facilities are the growth drivers of this market.
By geography, the market can be segmented into North America, Europe, Asia Pacific, and Rest of the world. Geographically, North America was observed to have the major share of cardiac output monitoring device market due to high healthcare awareness, prevalence of cardiovascular diseases and technological advancement in the region. Europe contributes to the second largest share in the cardiac output monitoring device market growth with raising ageing population. However, Asia Pacific region is expected to be the fastest growing due to the gradual adoption of improved technologies, emerging health care infrastructures, and raising population with cardiac problems and obesity. Followed by Rest of the world.
The major key players operating in cardiac output monitoring device market include Edwards Lifesciences Corporation, Cheetah Medical, PULSION Medical Systems SE, Philips Healthcare, LiDCO Group plc, Boston Scientific Corporation, GE Healthcare, and others. Bioreactance-based NICOM Cheetah Medical remains the topmost non-invasive market leader.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
Posted by at No comments:
Labels: , ,

Dental Fittings Market: Regional markets, technology developments, types, applications, and the competitive landscape

Orthodontics mainly deals with the correction of improper alignment of teeth by braces or apparent loss of teeth by dentures/artificial teeth. Orthodontics was initially chosen for children but now it is used ubiquitously. Technological advancements have reduced the stigma related with this treatment and now many dental fittings such as tongue and teeth colored braces are available commercially. Rising awareness of dental aesthetics and related advantages has resulted in increased acceptance of dental fittings amongst all age groups.
The dental fittings include dentures, archwires, anchorage appliances and ligatures. The braces or the brackets are meant to place the misaligned or crooked teeth in place. Braces are small squares attached to the front of the teeth by an orthodontic bonding agent and connected to each other via connectors or bands. Orthodontic bands are stainless steel, tooth colored material or transparent. Spacers are separating parts that fit between the teeth before the bands. Archwires guide braces with the movement of the teeth. Ligatures are small rubber bands which hold on to the archwires together. Traditionally braces were made up of metals, however, with technological advancements they are now available in ceramics. The braces are also made up of stainless steel, titanium or a mixture of both. The orthodontic archwires are of two types: coated metal and transparent non-metallic. Coated metal archwires are made up of nickel- titanium or of stainless steel and are coated with polytetrafluoroethylene (PTFE), parylene-polymer, and an epoxy-resin. Transparent nonmetallic arches are similar to metal arches which are made from glass spindle and are embedded in polymer matrix. The growing demand for aesthetic archwires has led to many advancements in archwires technology. These wires will continuously be developed on the basis of appearance, durability and flexibility. Non-metallic archwires may take over the future market as they are more preferred over the conventional metallic wires. Dentures are used to replace and support the missing teeth and the surrounding gum tissues. Dentures are of two types: complete ones and the partial ones. The partial ones are plastic partials or the metal partials, on the basis of the material used to attach to the teeth.
The dental fittings market is on an all-time high due to many regulatory reforms in most of the countries like reimbursement coverage, access to advanced technology, increased disposable income and increased rate of awareness about dental fittings treatment. Aspects such as rising awareness about dental fittings, cheaper availability of treatment and increasing health care expenditure may boost the growth of the dental fittings market in Asia Pacific. Attributing to rapid development in healthcare, infrastructure, government reforms and access to advanced dental fittings, China and India are most profitable markets in Asia. Also, easy availability of skilled orthodontists and supporting economy is expected to spur the growth of the dental fittings market in China and India.
Many of the companies are manufacturing dental fittings, and are adopting acquisitions and mergers, extensive R&D as measures to expand their geographic reach and introduction of novel products in to the market. Asia Pacific dental fittings market is expected to rise with context to volume, on basis of low product prices, less market penetration, disposable earning and improving healthcare expenditure. Also the awareness of dental aesthetics systems and dental cosmetic surgery will expectedly drive this market in North America and Europe. The advanced CAD/CAM technology and 3 Dimensional digital imaging may lead to growth in the industry. The CAD technology can support in making digital prostheses much faster. The global dental fittings market is dominated by few key players such as GC Orthodontics, Dentaurum, Henry Schein, Hangzhou Shinye, and Dental Morelli.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
Posted by at No comments:
Labels: , , , , ,

Wheelchairs and Medical Beds the Most Popular Products in Global Personal Mobility Devices Market

Global Personal Mobility Devices Market: Key Trends
The rising geriatric population around the world has emerged as a key driver of the global personal mobility devices market. Transparency Market Research (TMR) projects demand for these devices to steadily increase in Asia Pacific, as the population of aged people increases in India and China. Apart from the geriatric population, caregiving services are also essential for people suffering from disability. A rise in the number of people living with a disability, either temporary or permanent, will fuel demand for personal mobility devices.
Despite witnessing positive growth worldwide, the high cost of these mobility devices will limit their market’s expansion to an extent. The low acceptance of digitized devices will also negatively impact the market’s trajectory. Nevertheless, grants from international organizations and favorable policies will boost sales of personal mobility devices in the coming years.
As per TMR, the global personal mobility devices market stood at US$6.65 bn in 2014. Rising at a CAGR of 7.30% between 2015 and 2023, the market is expected to reach US$12.7 bn by the end of 2023.
Higher Purchasing Power of Consumers Puts North America in Dominant Position
North America currently leads the global personal mobility devices market. By revenue, the region held over 41.4% of the overall market in 2014, followed by Europe. Spurred by the rising geriatric population, coupled with the rising number of people with disability, the sales of personal mobility devices is expected to rise considerably in this region. North America has also proven lucrative for producers of technologically advanced devices. The region thus exhibits high demand digitized mobility devices. Furthermore, the increasing willingness among consumers to spend on advanced medical devices will provide improved sales opportunities to personal mobility devices manufacturers in North America.
Asia Pacific emerged as the third-largest market for personal mobility devices in 2014. However, TMR forecasts the regional market to rise at the highest CAGR during the forecast period. The increasing awareness about advanced medical devices, and their rising affordability, will boost demand for personal mobility devices in Asia Pacific. Furthermore, the increasing geriatric population reported in India and China, will augur well for the personal mobility devices market in Asia Pacific.
Advent of Electric Wheelchairs Fuels Growth of Medical Mobility Aids and Ambulatory Devices Segment
The global personal mobility devices market can be bifurcated into medical mobility aids and ambulatory devices and medical furniture and bathroom safety products. Of these, the medical mobility aids and ambulatory devices segment dominated the market in 2014. The segment is expected to report the fastest CAGR of 8.5% during from 2015 to 2023. In this segment, wheelchairs emerged as the dominant sub-category in 2014. The increasing incidence of disability related to age, disease, or any physical injury fuels demand for wheelchairs considerably. Furthermore, the demand for electric wheelchairs is expected to rise in the forthcoming years as they provide better outdoor performance and are easy to drive.
Besides this, the medical furniture and bathroom safety products segment is expected to witness rising demand for medical beds in the near future. Overall, the segment is expected to report steady growth through the forecast period.
Some of the leading players operating in the global personal mobility devices market are Amigo Mobility International, Inc., Argo Medical, ArjoHuntleigh, Drive Medical, Graham-Field Health Products Incorporated, and Hill-Rom Holdings, Inc.
Posted by at No comments:
Labels: , , ,

Interventional Radiology Market: Business Challenges, Emerging Technologies & Competitive Landscape

Global Interventional Radiology Market: Snapshot
The use interventional radiology procedures is witnessing a huge surge across the globe owing to their minimally invasive nature and benefits such as less recovery time and hospital stay. A number of interventional radiology procedures are being regularly used for the treatment of diseases such as cancer, cardiovascular diseases, and traumatic inquiries, the prevalence of which is rising at an alarming rate globally. The field of interventional radiology also holds immense promise owing to the wide range of applications and technological advancements.
As a result, the global interventional radiology market is poised to observe significant growth in the next few years. Transparency Market Research estimates that market will exhibit a CAGR of 5.8% over the period between 2016 and 2024. If the prediction holds true, the market, which valued at US$13.8 bn in 2015, is expected to reach US$22.9 bn by 2024.
Rising Numbers of Traumatic Injuries to Boost Demand for Embolization Procedures
View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/interventional-radiology-market.html
In terms of application, the global market for interventional radiology is examined for angiography, balloon angioplasty, embolization, vertebroplasty, biopsy, kyphoplasty, and RF ablation. Of these, the segment of embolization is expected to account for a share of 24.2% of the global market by 2024. The segment also holds the dominant position in the market presently and accounted for a 23.8% of the global market in 2015.
The rising prevalence of traumatic injuries across the globe is expected to drive the increased demand for embolization surgeries worldwide. According to the National Trauma Institute, traumatic injuries account for nearly 41 mn visits to emergency departments and over 2.3 mn hospital admissions. Traumatic injury is also a serious public health issue globally and is expected to lead to an increased demand for embolization surgeries in the near future.
The angiography segment is projected to account for a share of 21.0% in the global market by 2024. The rising global prevalence of strokes and high demand for minimally invasive surgeries will allow the segment to expand at a favorable pace over the forecast period. Biopsy and vertebroplasty-kyphoplasty are relatively smaller segments of the market, with a collective share of nearly 11.8% in the global market in 2015. The segment of biopsy is expected to register a CAGR of 5.6% during the forecast period owing to the increasing prevalence of breast cancer.
Asia Pacific to Lead to Promising Growth Opportunities
With a 38.4% share, the North America interventional radiology market held the top spot in the global market in 2015. Rising demand for minimal invasive procedures and an endless supply of technological advanced devices and equipment are the major factors supporting the growth of the North America market. The x-ray segment gained the leading position in North America in the same year, accounting for over half of the market. Owing to factors such as improvement in technology, rising incidences of a variety of cancers, and well-established healthcare facilities, the North America market for interventional radiology is expected to expand at a swift pace over the next few years as well.
Although North America will continue to account for a higher share in the global interventional radiology market as compared to other regional markets over the forecast period as well, it is expected to lose prominence to the market in Asia Pacific in terms of rate of growth. The Asia Pacific interventional radiology market is expected to exhibit a 7.1% CAGR from 2016 through 2024. Rising prevalence of a variety of cancers, rising geriatric population, improving healthcare facilities, and rising disposable incomes and the relative rise in healthcare spending will play a key role in driving the Asia Pacific interventional radiology market over the said period.
The global interventional radiology market features a consolidated competitive landscape, wherein a relatively small number of companies account for a majority share in the market. Some of the key players operating in the global Interventional Radiology market are Agfa-Gevaert N.V., Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Medtronic plc., and Philips Healthcare.
Posted by at No comments:
Labels: , , , , , ,

Increased Adoption of Minimally Invasive Surgeries to Drive Demand for Transcatheter Embolization and Occlusion Devices

Transcatheter Embolization and Occlusion Devices Market: Snapshot
The transcatheter embolization and occlusion (TEO) devices market has witnessed strong growth in the past few years due to the rising focus on innovation, resulting in higher product approvals and product launches globally. The market is also characterized by significant research and development leading to several technological innovations.
In terms of revenue, the global TEO devices market was valued at US$2.4 bn in 2015 and is projected to reach US$4.8 bn by 2024 at a CAGR of 7.9% therein. In terms of volume, the global market is anticipated to register a CAGR of 8.1% from 2016 to 2024.
High Prevalence of Obesity Drives Use of TEO Devices in Treating Peripheral Vascular Diseases
Embolization coils are the leading products in the market, as these are one of the oldest embolization products available in the market. However, the embolization particles and flow diverter devices segments are expected to record a high CAGR during the forecast period.
Based on application, the peripheral vascular disease segment dominates the transcatheter embolization and occlusion devices market. This segment is expected to continue its lead through 2024 due to a growing geriatric population, changing lifestyles leading to a high prevalence of obesity, and the rising demand for minimally-invasive procedures. However, the oncology segment is expected to record a high CAGR during the forecast period due to the rising prevalence of cancer across the globe.
By end use, the hospitals segment captured a considerable market share and is likely to remain a key segment in the transcatheter embolization and occlusion devices market, expanding at a high CAGR during the forecast period.
Booming Medical Tourism Industry Contributing toward Growth of APAC TEO Devices Market
North America accounted for a major share in the global transcatheter embolization and occlusion devices market in 2015 due to the presence of leading market players in the region. Most of these companies operating in the region have made a series of strategic acquisitions, which contributes to an increase in their market share. The growing prevalence of cancer in the region is one of the primary factors contributing to the growth of the transcatheter embolization and occlusion devices market. According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015 alone. Well-established reimbursement policies by private or public organizations for TEO devices is also a major factor spurring the adoption of these devices North America.
Get Free Sample Research Report:
The transcatheter embolization and occlusion devices market in Asia Pacific is expected to expand at a high CAGR during the forecast period. A large patient pool and rising awareness about transcatheter embolization procedures are the key factors driving the adoption of TEO devices in the region. The booming medical tourism industry, driven by rising government support and the incorporation of different schemes by the government to avail better treatment for patients, is also expected to propel the transcatheter embolization and occlusion devices market. An increase in the number of localized manufacturers and the strengthening of the distribution network in Asia Pacific due to a rapidly growing economy offer significant benefits for market players as far as investments are concerned. A surge in the prevalence of neurovascular diseases and cancer in several countries across Asia Pacific is projected to fuel the market in the coming years.
Major players operating in the transcatheter embolization and occlusion devices market include Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Medtronic plc, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., Stryker Corporation, and Terumo Corporation.
Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)